Following the recommendations of the authorities for the coronavirus pandemic, SARA Pharm has taken the necessary measures to ensure the continuity of its activity. The current projects are on-going. The laboratory is operational and the necessary precautions have been taken to allow the safe reception of samples. We do not foresee any impact on our activity to date. In the event of an evolution, we will not fail to keep you informed.

December 18th, 2017

We are proud to announce that SARA Pharm has been awarded an Horizon 2020 grant (H2020-MSCA-RISE-2017 for the CLATHROPROBES project whose primary objective is to the design and development of novel, highly efficient chiroptical, luminescent probes for sensing and structural studies of biomolecules based on cage metal complexes as molecular reporters.

Our partners in the project are UNIVERSITAT WIEN (Austria), FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG (Germany), UNIWERSYTET WROCLAWSKI (Poland) and SC Princeton Biomolecular Research Labs (Ukraine).